These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32926644)

  • 1. Cancer Screening and Genetic Testing Recommendations for Relatives of Men Undergoing Prostate Cancer Germline Testing: Implications for Practice.
    Giri VN; Hyatt C; Leader A
    J Urol; 2020 Dec; 204(6):1116-1118. PubMed ID: 32926644
    [No Abstract]   [Full Text] [Related]  

  • 2. NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.
    Carroll PH; Mohler JL
    J Natl Compr Canc Netw; 2018 May; 16(5S):620-623. PubMed ID: 29784740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
    Aslanian HR; Lee JH; Canto MI
    Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations of germline testing in prostate cancer screening.
    Polascik TJ; Orabi H
    Can J Urol; 2019 Oct; 26(5 Suppl 2):46-47. PubMed ID: 31629431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USPTF Prostate Cancer Screening Recommendations-A Step in the Right Direction.
    Carroll PR
    JAMA Surg; 2018 Aug; 153(8):701-702. PubMed ID: 29801146
    [No Abstract]   [Full Text] [Related]  

  • 6. Is Prostate-Specific Antigen Screening "Proven Ineffective Care"?
    Barry MJ; Albertsen PC
    Ann Intern Med; 2016 May; 164(10):687-8. PubMed ID: 26902323
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for Prostate Cancer: Recommendation Statement.
    Am Fam Physician; 2018 Oct; 98(8):Online. PubMed ID: 30277733
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for Prostate Cancer.
    Wolff T; Jadotte YJ
    Am Fam Physician; 2018 Oct; 98(8):537-538. PubMed ID: 30277736
    [No Abstract]   [Full Text] [Related]  

  • 9. Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer.
    Cooperberg MR; Lin DW; Morgan TM; Chapin BF; Chen RC; Eggener SE
    J Urol; 2022 Feb; 207(2):262-264. PubMed ID: 34775795
    [No Abstract]   [Full Text] [Related]  

  • 10. Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand.
    Mathew P; Hachem H; Han P
    JAMA Oncol; 2018 Apr; 4(4):453-454. PubMed ID: 29470576
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
    Loeb S; Giri VN
    Eur Urol Oncol; 2021 Feb; 4(1):1-9. PubMed ID: 33390340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761
    [No Abstract]   [Full Text] [Related]  

  • 13. Prostate Cancer Screening.
    Dunn MW
    Semin Oncol Nurs; 2017 May; 33(2):156-164. PubMed ID: 28343840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for earlier and less frequent prostate cancer screening.
    Carter HB
    Urology; 2001 Nov; 58(5):639-41. PubMed ID: 11711328
    [No Abstract]   [Full Text] [Related]  

  • 15. Introducing the 2010 American Cancer Society prostate cancer screening guideline.
    Brawley OW; Gansler T
    CA Cancer J Clin; 2010; 60(2):68-9. PubMed ID: 20200111
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate Cancer Screening in a New Era of Genetics.
    Cheng HH; Pritchard CC; Montgomery B; Lin DW; Nelson PS
    Clin Genitourin Cancer; 2017 Dec; 15(6):625-628. PubMed ID: 28697982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current guidelines for prostate cancer screening: A systematic review and minimal core proposal.
    Araujo FAGDR; Oliveira U
    Rev Assoc Med Bras (1992); 2018 Mar; 64(3):290-296. PubMed ID: 29641784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AGO Austria recommendations for genetic testing of patients with ovarian cancer.
    Marth C; Hubalek M; Petru E; Polterauer S; Reinthaller A; Schauer C; Scholl-Firon T; Singer CF; Zschocke J; Zeimet AG
    Wien Klin Wochenschr; 2015 Aug; 127(15-16):652-4. PubMed ID: 26109557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of recent screening recommendations on prostate cancer screening in a large health care system.
    Aslani A; Minnillo BJ; Johnson B; Cherullo EE; Ponsky LE; Abouassaly R
    J Urol; 2014 Jun; 191(6):1737-42. PubMed ID: 24342148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.